Loading clinical trials...
Loading clinical trials...
A Phase II, Randomized, Observer-masked, Placebo-and Active-controlled, Parallel-group, Multi-center Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution Compared With Latanoprost and Placebo in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
Conditions
Interventions
DE-117 ophthalmic solution
latanoprost ophthalmic solution
+1 more
Locations
7
United States
Newport Beach, California, United States
Morrow, Georgia, United States
Kansas City, Missouri, United States
Rochester, New York, United States
Cleveland, Ohio, United States
Austin, Texas, United States
Start Date
May 1, 2013
Primary Completion Date
August 1, 2013
Completion Date
September 1, 2013
Last Updated
April 18, 2018
Lead Sponsor
Santen Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions